current companies
- Filter:
- All
- #
- a
- b
- c
- d
- e
- f
- g
- h
- i
- j
- k
- l
- m
- n
- o
- p
- q
- r
- s
- t
- u
- v
- w
- x
- y
- z
Artful solutions to scientific challenges
3X Genetics
Screening the world's population for Myotonic Dystrophy and other trinucleotide repeat disorders.
AAVinue, Inc.
AAVinue, Inc. is a pre-seed stage biotech startup, pioneering development of advanced AAVs (adeno-associated viruses) capable of evading neutralizing antibodies and providing deep tissue penetration to allow increased patient access to life-saving therapies.
Advirna
Innovative solutions for oligonucleotide delivery.
Boston Harbor Biotechnologies
Boston Harbor Biotechnologies was established by a team of experts to meet the growing demand for comprehensive services within the cell and gene therapy (CGT) community. Our mission is to support a broad spectrum of research and development needs, from discovery through process and assay development to IND-enabling studies and CMC tech transfer readiness.
CG Scientific
Novel technology for extracting mesenchymal stem cells.
Codomax
Codomax applies its Epi-MAX platform technology to re-engineer strains and expression vectors to enable maximal production of difficult-to-express biologics.
Conifer Life Sciences Group
Conifer Life Sciences is a firm fostering development of new ventures in the life science tools industry.
Conigen Bioscience
Conigen Bioscience Inc. is a life science tools company that integrates state-of-art immunology, virology, molecular biology and cell biology to create new reagents and high-quality assays for discovery, development, and manufacturing.
Eascra Biotech
Based on DNA nanotechnology, Eascra's novel family of Janus base nanomaterials provides highly effective, super biocompatible solutions that enable enhanced therapeutic delivery and regenerative medicine for articular cartilage, central nervous system disorders, solid tumors, and other chronic conditions.
EasyText.AI
Make web text so simple we understand it the first time we read it.
Elangen, Inc.
Elangen, Inc. - Safer ways to cure disease
Enamel Pure
Healthy Enamel, Pure Smiles
Fornax Biotech
Next-generation sequencing, bioinformatics and RNA-related services.
Hessian Labs
Hessian Labs harnesses information from platelets, a highly responsive biological system, to build non-invasive tools with ‘next level’ diagnostic capability.
Highspin Biosystems
Leal Therapeutics
A CNS-focused biotech start-up working to develop a pipeline of novel, ultra-precise therapeutics for major CNS indications.
MassVentures
MassVentures is a venture studio at its core with an emphasis on academic spinouts and building diverse teams that convert research and early-stage ideas into companies serving underserved areas in the Commonwealth. By providing not only financial resources but also strategic direction, operational support, and access to a network of experts, MassVentures provides portfolio companies a greater chance of success.
Metro Biotech
First-in-class, small-molecule NAD+ enhancers to treat rare diseases and combat aging.
Microgradient Fluidics
Microfluidics for quantifying biomolecule stability and interactions
Neurotech Pharmaceuticals, Inc.
A long-term solution to slow disease progression, helping patients maintain vision and quality of life.
Non Human Primate Reagent Resource (NHPRR)
NHPRR supports innovation, reproducibility, and translation of preclinical research with high-quality biologics development
Phio Pharmaceuticals
Phio's focus is centered on the application of self-delivering RNAi therapies in the field of immuno-oncology. Our INTASYL technology is the only self-delivering siRNA technology focused on immuno-oncology. INTASYL is designed to silence specific genes that are implicated in the proliferation of solid cancer tumors.
Prana Biosciences
Using innovation to reformulate existing drugs.
Prothia
Device specialists in cardiovascular, perinatal and rehabilitation applications.
Quantum Technology Group
Quantum's unique manufacturing process presents the ability to produce nontoxic quantum dots and deliver bulk manufacturing
SignaBlok, Inc.
Multi-Indication Cancer Platform Therapeutic
SpadXTech
SpadXTech seeks to significantly reduce CO2 emissions through the manufacturing of various carbon negative cellulose-based materials. Through its material platform technology and versatility, they can potentially impact the packaging, textiles, transportation, filtration, and the construction industries.
Spatial Surgical
Novel first in class orthopedic laser system that rapidly and safely ablates soft tissue and bone through a single handpiece
Splice Histology
Splice provide timely, high-quality, individual histopathology services when you need them.
Targeted Cell Therapies
Novel oral delivery treatment for Gaucher disease.
Trilogie Bioscience
VirRNA
Volta Energy
Volta Energy is developing next generation electrochemical energy storage technologies for renewable electricity including flow batteries and electrolyzers.
X Therapeutics
Startup developing a new generation of medicines against infectious diseases
ZATA Pharmaceuticals
Transforming blood transfusion through pathogen inactivation.